Garcia-Perez, L.; Ordas, A.; Canté-Barrett, K.; Meij, P.; Pike-Overzet, K.; Lankester, A.; Staal, F.J.T.
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side. Pharmaceutics 2020, 12, 549.
https://doi.org/10.3390/pharmaceutics12060549
AMA Style
Garcia-Perez L, Ordas A, Canté-Barrett K, Meij P, Pike-Overzet K, Lankester A, Staal FJT.
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side. Pharmaceutics. 2020; 12(6):549.
https://doi.org/10.3390/pharmaceutics12060549
Chicago/Turabian Style
Garcia-Perez, Laura, Anita Ordas, Kirsten Canté-Barrett, Pauline Meij, Karin Pike-Overzet, Arjan Lankester, and Frank J. T. Staal.
2020. "Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side" Pharmaceutics 12, no. 6: 549.
https://doi.org/10.3390/pharmaceutics12060549
APA Style
Garcia-Perez, L., Ordas, A., Canté-Barrett, K., Meij, P., Pike-Overzet, K., Lankester, A., & Staal, F. J. T.
(2020). Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side. Pharmaceutics, 12(6), 549.
https://doi.org/10.3390/pharmaceutics12060549
